Case pres drugs.docx
-
Upload
glaizalyn-fabella-tagoon -
Category
Documents
-
view
217 -
download
0
Transcript of Case pres drugs.docx
-
8/14/2019 Case pres drugs.docx
1/6
Drug Pharmacologic
actionIndication Contraindication Side effect Nursing responsibility
Classification:
Antipyretic Analgesic
(nonopioid)
Anti-inflammatory Antirheumatic Antiplatelet Salicylate NSAIDName:Aspirin
Dosage:
ADULTS
Minor aches andpains: 325650
mg q 4 hr.
Arthritis andrheumatic
conditions: 3.26g/day in divided
doses.
Acute rheumaticfever: 58 g/day;
Analgesic andantirheumatic
effects are
attributable to
aspirins ability to
inhibit the
synthesis of
prostaglandins,
important
mediators of
inflammation.Antipyretic effects
are not fully
understood, but
aspirin probably
acts in the
thermoregulatory
center of the
hypothalamus to
block effects of
endogenous
pyrogen by
inhibiting
synthesis of the
prostaglandin
Mild to moderatepain
Fever Inflammatory
conditions
rheumatic fever,
rheumatoid
arthritis,
osteoarthritis
Reduction of riskof recurrent TIAs
or stroke in males
with history of TIA
due to fibrin
platelet emboli
Reduction of riskof death or
nonfatal MI in
patients with
history of
infarction or
unstable angina
pectoris
Contraindicatedwith allergy to
salicylates or
NSAIDs (more
common with nasal
polyps, asthma,
chronic urticaria);
allergy to tartrazine
(cross-sensitivity to
aspirin is common);
hemophilia,bleeding ulcers,
hemorrhagic states,
blood coagulation
defects,
hypoprothrombine
mia, vitamin K
deficiency
(increased risk of
bleeding)
Use cautiously withimpaired renal
function;
chickenpox,
Nausea, GIupset, heartburn
(take drug with
food); easy
bruising, gum
bleeding (related
to aspirins
effects on blood
clotting).
Report ringing inthe ears;
dizziness,
confusion;
abdominal pain;
rapid or difficult
breathing;
nausea,
vomiting, bloody
stools.
BLACK BOXWARNING: Do not use
in children and
teenagers to treat
chickenpox or flu
symptoms without
review for Reyes
syndrome, a rare but
fatal disorder.
Give drug with food orafter meals if GI upsetoccurs.
Give drug with full glassof water to reduce risk
of tablet or capsule
lodging in the
esophagus.
Do not crush, andensure that patient does
not chew SRpreparations.
Do not use aspirin thathas a strong vinegar-
like odor.
-
8/14/2019 Case pres drugs.docx
2/6
modify to maintain
serum salicylate
level of 1530
mg/dL.
TIAs in men:1,300mg/day in divided
doses (650 mg bid
or 325 mg qid).
MIprophylaxis: 75
325 mg/day.
intermediary.
Inhibition of
platelet
aggregation is
attributable to theinhibition of
platelet synthesis
of thromboxane
A2, a potent
vasoconstrictor
and inducer of
platelet
aggregation. This
effect occurs at
low doses and
lasts for the life of
the platelet (8
days). Higher
doses inhibit the
synthesis of
prostacyclin, a
potent vasodilator
and inhibitor of
platelet
aggregation.
MI prophylaxis Unlabeled use:
Prophylaxis
against cataract
formation with
long-term use
influenza (risk of
Reyes syndrome in
children and
teenagers);
children with feveraccompanied by
dehydration;
surgery scheduled
within 1 wk;
pregnancy
(maternal anemia,
antepartal and
postpartal
hemorrhage,
prolonged
gestation, and
prolonged labor
have been
reported; readily
crosses the
placenta; possibly
teratogenic;
maternal ingestion
of aspirin during
late pregnancy has
been associated
with the following
adverse fetal
WARNING: Instituteemergency procedures
if overdose occurs:
Gastric lavage,
induction of emesis,activated charcoal,
supportive therapy.
Take extra precautionsto keep this drug out of
the reach of children;
this drug can be very
dangerous for children.
Use the drug only assuggested; avoidoverdose. Avoid the use
of other over-the-
counter drugs while
taking this drug. Many
of these drugs contain
aspirin, and serious
overdose can occur.
Take the drug with foodor after meals if GI
upset occurs.
Do not cut, crush, orchew sustained-release
products.
-
8/14/2019 Case pres drugs.docx
3/6
effects: low birth
weight, increased
intracranial
hemorrhage,
stillbirths, neonataldeath); lactation.
Over-the-counteraspirins are equivalent.
Price does not reflect
effectiveness.
Drug Pharmacologic action Indication Contraindication Side effect Nursingresponsibility
Classification:
Adenosinediphosphate
(ADP) receptorantagonist
AntiplateletGeneric name:Clopidogrel
Brand Name:Plavix
Dosages:
ADULTS
Recent MI, stroke, or
established peripheral
arterial disease:75 mg
PO daily.
Acute coronary
Inhibits plateletaggregation byblocking ADP receptorson platelets, preventingclumping of platelets.
Treatment ofpatients at risk for
ischemic events
history of MI,
ischemic stroke,
peripheral artery
disease
Treatment ofpatients with acute
coronary syndrome
Contraindicatedwith allergy
to clopidogrel,
active pathological
bleeding such as
peptic ulcer or
intracranial
hemorrhage,
lactation.
Use cautiously withbleeding disorders,
recent surgery,
hepatic impairment,
pregnancy.
Dizziness, light-headedness (this
may pass as you
adjust to the drug);
headache (lie down
in a cool
environment and
rest; OTC
preparations may
help); nausea,
gastric distress (eat
frequent small
meals); prolonged
bleeding (alert
doctors, dentists of
this drug use).
Report skin rash,chest pain, fainting,
Provide small,frequent meals if GI
upset occurs (not
as common as with
aspirin).
Provide comfortmeasures and
arrange for
analgesics if
headache occurs.
-
8/14/2019 Case pres drugs.docx
4/6
syndrome:300 mg PO
loading dose, then 75
mg/day PO with
aspirin, given at a dose
from 75325 mg oncedaily
severe headache,
abnormal bleeding.
Drug Pharmacologic action
Indication Contraindication Side effect Nursing responsibility
Classification:-Anticoagulant-Low MolecularWeight Heparin
GENERIC NAME:enoxaparin
BRAND NAME:Lovenox
Dosage:- DVT
prophylaxis:30 mgsubcutaneously bidwith initial dose soonas possible aftersurgery, not more
than 24 hr aftersurgery. Continue throughout thepostoperative periodfor 710 days; then40 mg dailysubcutaneously for
Low-molecular-weightheparin thatinhibitsthrombusand clotformationby blockingfactor Xa,factor IIa,preventingtheformation ofclots.
Prevention ofDVT, which maylead to pulmonaryembolism followinghip replacement,knee replacementsurgery, abdominalsurgery
Prevention ofischemiccomplications ofunstable anginaand nonQ-waveMI
Treatment of DVT,pulmonary emboluswith warfarin
Prevention of DVT
in medical patientswho are at riskfor thromboemboliccomplications dueto severelyrestricted mobilityduring acute
Contraindicatedwithhypersensitivityto enoxaparin,heparin,porkproducts;severethrombocytopenia;uncontrolledbleeding.
Usecautiously
withpregnancy orlactation,history ofGI bleed,spinal
bleeding.Fever,nausea,diarrhea, and fluidretention are common.Less commonly,enoxaparin caninduceabnormal livertests in the blood,suggesting mild damageto the liver, and areduction in bloodplatelets and red bloodcells. Mild local irritation,pain,hematoma,ecchymosis, anderythema may occur atthe site of injection.Hypersensitivity reactionsalso may occur.
- Give drug as soon as possibleafter hip surgery, within 12 hr ofknee surgery, and within 2hr preoperatively for abdominalsurgery.- Give deep subcutaneousinjections; do notgive enoxaparin by IM injection.- Administer by deep subcutaneousinjection; patient should be lyingdown. Alternate between the leftandright anterolateral and posterolateral abdominal wall. Introduce thewhole length of the needle into askin fold held between the thumband forefinger; hold the skin foldthroughout the injection.
-Apply pressure to all injection
sites after needle is withdrawn;inspect injection sites for signsof hematoma; do not massageinjection sites.- Do not mix with other injectionsor infusions.
http://www.medicinenet.com/script/main/art.asp?articlekey=361http://www.medicinenet.com/script/main/art.asp?articlekey=24732http://www.medicinenet.com/script/main/art.asp?articlekey=1900http://www.medicinenet.com/script/main/art.asp?articlekey=6274http://www.medicinenet.com/script/main/art.asp?articlekey=6274http://www.medicinenet.com/script/main/art.asp?articlekey=104680http://www.medicinenet.com/script/main/art.asp?articlekey=104680http://www.medicinenet.com/script/main/art.asp?articlekey=6274http://www.medicinenet.com/script/main/art.asp?articlekey=6274http://www.medicinenet.com/script/main/art.asp?articlekey=1900http://www.medicinenet.com/script/main/art.asp?articlekey=24732http://www.medicinenet.com/script/main/art.asp?articlekey=361 -
8/14/2019 Case pres drugs.docx
5/6
up to 3 wk may beused.-Patients undergoingabdominalsurgery:40 mg/daysubcutaneously
begun within 2hr preoperatively andcontinued for 710days.-Outpatient DVTtreatment:1 mg/kgsubcutaneously q 12hr.-Unstable angina andnonQ-wave MI:1mg/kgsubcutaneously q 12hr for 28 days.
-Inpatient DVTtreatment:1.5 mg/kgsubcutaneously oncedaily.-Prevention of DVT inhigh-risk medical
patients:40 mg/daysubcutaneously for611 days, has beenused up to 14 days.
illnesses tap,spinal/epiduralanesthesia
- Store at room temperature; fluidshould be clear, colorless to paleyellow.- Provide for safety measures(electric razor, soft toothbrush) toprevent injury to patient who is at
risk for bleeding.- Check patient for signs ofbleeding; monitor blood tests.- Alert all health care providers thatpatient is on enoxaparin.- Discontinue and initiateappropriate therapyif thromboembolic episode occursdespite enoxaparin therapy.
.
Drug Pharmacologic action Indication Contraindication Side effect Nursingresponsibility
Classification:Beta- adrenergic
Unknown. A selectivebeta blocker that
HypertensionAcute MI
-Hypersensitive todrug.
-CV: hypotension-GI: nausea and
-Always check patientsapical pulse
-
8/14/2019 Case pres drugs.docx
6/6
blocking agents
GENERIC NAME:Metoprolol HCL
BRAND NAME:
Lopressor
selectively blocksbeta1 receptors;decreases cardiacoutput, peripheralresistance, and cardiacoxygen consumption;
and depresses renninsecretion
AnginaPectoris
-Patient with sinusbradycardia,-cardiogenic shockand heart failure
vomiting-Respi: dyspnea-Skin: rash
-Monitor BP-Store drug at roomtemperature.-Inform patient aboutthe side effects andadverse effects of the
medication.-Advise patient to takeit with meals.-Tell patient to report ifhe/she feels shortnessof breath.-Tell patientThat metoprolol is notadvisable tobreastfeeding mothers.-Advise not towithdrawn drugabruptly